The Future of Diversity in Clinical Trials: Real-World Evidence
This episode of tHEORetically Speaking features real-world evidence experts Alexandrina Balanean, Parisa Asgarisabet, and Danielle Gentile from Cardinal Health discussing the problems caused by lack of diverse representation in clinical trials.
PhRMA President Discusses Patient Centricity in Value Assessments
President of Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Eileen Cannon shared her thoughts on adding a patient-centered component [...]
New Cytel Whitepaper on Clinical Trial Optimization Using Pareto Efficiency
Cytel’s new whitepaper on optimizing clinical trial design discusses how to best allocate resources. Thoughtfully planning a clinical trial requires [...]